AI English summary of an SEC filing — figures as filed
The company said its board approved, effective December 18, 2024, the cancellation of 1,150,000 PSUs that Dr. Sridhar received on May 12, 2021 under the 2021 equity package. The canceled awards include 1,000,000 PSUs tied to stock price performance through 2025 and 150,000 PSUs tied to financial performance.
Key points
AI summaryThe company said its board approved, effective December 18, 2024, the cancellation of 1,150,000 PSUs that Dr. Sridhar received on May 12, 2021 under the 2021 equity package. The canceled awards include 1,000,000 PSUs tied to stock price performance through 2025 and 150,000 PSUs tied to financial performance.
The company said that because the 2021 PSUs no longer have retentive value, it canceled them in place of granting Dr. Sridhar a 3-year, front-loaded equity package of 2025 consisting of 1,500,000 PSUs and 500,000 RSUs.
The company said the performance criteria for the 2025 Equity Package PSUs are equally weighted between product revenue growth and adjusted product gross margin, and Dr. Sridhar can earn up to 300% of the target PSUs. The PSUs have a 3-year cliff performance vesting period, and the RSUs vest in equal annual installments over 3 years.
The company said its board approved a one-time grant of 600,000 PSUs effective December 18, 2024. 300,000 of the PSUs vested in full on the same day, and the remaining 300,000 PSUs will vest after the Compensation Committee certifies that specific, objective criteria have been achieved before December 31, 2027.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Board cancels 1,150,000 Dr. Sridhar PSUs in 2021
The company said its board approved, effective December 18, 2024, the cancellation of 1,150,000 PSUs that Dr. Sridhar received on May 12, 2021 under the 2021 equity package. The canceled awards include 1,000,000 PSUs tied to stock price performance through 2025 and 150,000 PSUs tied to financial performance.
Source · Based on the filing body and exhibits
Reasons for cancellation and 3-year upfront equity package
The company said that because the 2021 PSUs no longer have retentive value, it canceled them in place of granting Dr. Sridhar a 3-year, front-loaded equity package of 2025 consisting of 1,500,000 PSUs and 500,000 RSUs.
Source · Based on the filing body and exhibits
2025 Equity Package PSU performance criteria
The company said the performance criteria for the 2025 Equity Package PSUs are equally weighted between product revenue growth and adjusted product gross margin, and Dr. Sridhar can earn up to 300% of the target PSUs. The PSUs have a 3-year cliff performance vesting period, and the RSUs vest in equal annual installments over 3 years.
Source · Based on the filing body and exhibits
600,000 PSUs one-time grant
The company said its board approved a one-time grant of 600,000 PSUs effective December 18, 2024. 300,000 of the PSUs vested in full on the same day, and the remaining 300,000 PSUs will vest after the Compensation Committee certifies that specific, objective criteria have been achieved before December 31, 2027.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…